News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Melatonin supplementation linked to better sleep quality in ICU patients
By Marilynn Larkin NEW YORK (Reuters Health) - In intensive care unit (ICU) patients taking analgesics and/or sedatives, a melatonin supplement improved sleep quality in a placebo-controlled trial,
UPDATE 1-WHO: Nations mulling Gilead's COVID drug should consider trial flop, too
(Adds FDA comment) By Stephanie Nebehay and John Miller GENEVA/ZURICH (Reuters) - Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a
RPT-AstraZeneca resumes U.S. COVID-19 vaccine trial and J&J prepares to do same next week
(Adds commentary from companies on trial; adds bylines; publishes to additional subscribers) By Julie Steenhuysen and Carl O'Donnell (Reuters) - AstraZeneca Plc has resumed the U.S. trial of its
Fewer than half of physicians vote
By Linda Carroll (Reuters Health) - Just half of practicing physicians are registered to vote and not all of them actually show up at the polls, a new U.S. study finds. An analysis of data on
Breastfeeding tied to reduced risk of serious infant infections
By Lisa Rapaport (Reuters Health) - Longer duration of breastfeeding, as well as exclusive breastfeeding, are associated with lower risk of infant infections requiring hospitalization, a Danish study
After total joint replacement, amateur golfers play more often
By Will Boggs NEW YORK (Reuters Health) - Amateur golfers who have a total joint replacement are able to play more frequently than they did before surgery, though their golf handicap suffers slightly,
AstraZeneca resumes U.S. COVID-19 vaccine trial, optimism seen for J&J
By Reuters Staff (Reuters) - AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by U.S. regulators, the company said on Friday. AstraZeneca's U.S. trial was
Protesters gather across Poland after court curbs abortion rights
By Alicja Ptak and Lewis Macdonald WARSAW/GDYNIA (Reuters) - Thousands protested across Poland on Friday despite coronavirus restrictions, a day after the top court banned almost all grounds for
U.S. faces half a million COVID-19 deaths by end-February, study finds
By Kate Kelland LONDON (Reuters) - More than a half million people in the United States could die from COVID-19 by the end of February, but around 130,000 of those lives could be saved if everybody
WHO: Nations mulling Gilead's COVID drug should consider trial flop, too
By Stephanie Nebehay and John Miller GENEVA/ZURICH (Reuters) - Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a trial where the
WHO's Tedros says countries on 'dangerous track' in pandemic
By Reuters Staff GENEVA (Reuters) - The world is now at a critical juncture in the COVID-19 pandemic and some countries are on a dangerous path, facing the prospect of health services collapsing under
Transformative action required to improve pain management in kids
By Will Boggs MD NEW YORK (Reuters Health) - Several transformative goals need to be pursued simultaneously to improve the management of pediatric pain, which is commonly unrecognized and undertreated
Following bad sleep, drink coffee after breakfast, not before
By Scott Baltic NEW YORK (Reuters Health) - Strong coffee first thing in the morning after a lousy night's sleep might seem like a good idea, but it actually isn't, researchers say. The reason? The
Limited data do not support use of convalescent plasma for COVID-19
By Will Boggs MD NEW YORK (Reuters Health) - There are insufficient data to support the use of convalescent plasma or hyperimmune immunoglobulin for patients hospitalized with COVID-19, according to
Unique Alzheimer's disease risk loci found in African Americans
By Anne Harding NEW YORK (Reuters Health) - Researchers have identified several Alzheimer's disease risk loci unique to African Americans, according to a new report. The novel risk loci are near or
Previous cesarean no bar to external cephalic version
By David Douglas NEW YORK (Reuters Health) - Women with previous cesarean delivery are not significantly more likely to fail external cephalic version for breech presentation, although their rate of
Rapid COVID-19 tests key to infection control, improved patient outcomes
By Megan Brooks NEW YORK (Reuters Health) - Rapid, point-of-care testing (POCT) for suspected COVID-19 infection significantly reduces time to results and may improve infection control and patient
Finerenone improves outcomes in chronic kidney disease with diabetes
By Megan Brooks NEW YORK (Reuters Health) - In patients with chronic kidney disease (CKD) and type-2 diabetes, treatment with the investigational drug finerenone protects against CKD progression and
Black children half as likely to undergo surgery, twice as likely to die during reoperation
By Rob Goodier NEW YORK (Reuters Health) - Black children in the U.S. are twice as likely to die during unplanned reoperations as their white peers, but half as likely to undergo surgeries in the
German health minister expects COVID-19 vaccine in early 2021 - Spiegel
By Reuters Staff BERLIN (Reuters) - Germany's health minister expects a COVID-19 vaccine to be available early next year and believes a large proportion of Germans who want the shot could be
As COVID-19 cases spike, pneumonia vaccine demand rockets and Europe runs low
By Emilio Parodi, Ludwig Burger and Michael Erman MILAN/FRANKFURT/NEW YORK (Reuters) - As COVID-19 infections rise, people seeking to avoid one lung disease compounding another are queuing up to get
Don't give up on COVID-19 plasma, experts say, after study finds no benefit
By Kate Kelland LONDON (Reuters) - Researchers called on Friday for more research into using blood from recovered COVID-19 patients - or so-called convalescent plasma - as a potential treatment, after
Integrase strand transfer inhibitors unlikely to cause birth defects in HIV-positive pregnant women
By Marilynn Larkin NEW YORK (Reuters Health) - HIV-positive pregnant women taking integrase strand transfer inhibitors (INSTIs) don't seem to be at significantly greater risk of adverse pregnancy
REFILE-Earlier physical therapy referral tied to better sciatica outcomes
(Corrects source's name in last paragraph of story published October 5.) By Lisa Rapaport (Reuters Health) - People with recent-onset back pain with sciatica who receive four weeks of physical therapy
Adjunctive psychotherapy benefits outpatients with bipolar disorder
By Lisa Rapaport (Reuters Health) - People with bipolar disorder benefit from certain forms of psychotherapy, particularly skills-based interventions, combined with medication, a systematic review and
Hypothyroidism in pregnant woman may raise child's risk of ADHD
By Linda Carroll (Reuters Health) - Low levels of maternal thyroid hormone during the first three months of pregnancy may influence a fetus's brain development leaving the child at a greater risk of
Gilead's remdesivir gets U.S. FDA approval for use in hospitalized COVID-19 patients
By Reuters Staff (Reuters) - The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the
Radiologists supported frontline workers during early pandemic days
By Carolyn Crist NEW YORK (Reuters Health) - During the height of the initial COVID-19 surge in New York, radiologists volunteered to help with daily clinical rounds and communicate with families,
TGF-beta signaling impairs T cell-mediated cancer immunity
By Will Boggs MD NEW YORK (Reuters Health) - Transforming growth factor (TGF)-beta impairs the ability of CD4+ T cells to prevent cancer progression, but blocking TGF-beta signaling in these cells
Expected clinical trajectory of severe bronchiolitis doesn't pass muster in new study
By Reuters Staff NEW YORK (Reuters Health) - A new study challenges the notion that bronchiolitis symptoms peak on days three to five of illness in hospitalized infants. "Severe bronchiolitis is a
FACTBOX-Abortion rights across Europe
By Reuters Staff (Reuters) - Poland's Constitutional Tribunal ruled on Thursday that abortion due to foetal defects was unconstitutional, distancing the predominantly Catholic country further from
Pfizer, J&J urge clarity from FDA on future of COVID-19 vaccine trials once a vaccine is available
By Ankur Banerjee (Reuters) - Pfizer Inc and Johnson & Johnson are seeking input from a U.S. Food and Drug Administration advisory committee on retaining and attracting volunteers for COVID-19 vaccine
Britain authorises temporary use of flu vaccine to help meet demand
By Reuters Staff LONDON (Reuters) - Britain has authorised the temporary use of the Flublok flu vaccine and ordered millions of doses as it seeks to give jabs to more people during the coronavirus
Extracorporeal CO2 removal effective in status asthmaticus
By Reuters Staff NEW YORK (Reuters Health) - Venovenous extracorporeal carbon dioxide removal (ECCO2R) may be lifesaving in patients with status asthmaticus refractory to maximal medical therapy,
Risankizumab improves patient-reported outcomes in moderate to severe psoriasis
By Will Boggs MD NEW YORK (Reuters Health) - Risankizumab treatment significantly improves symptoms, health-related quality of life and mental health among patients with moderate to severe psoriasis,
Glycine/N-acetylcysteine supplementation may slow HIV-related premature aging
By Will Boggs MD NEW YORK (Reuters Health) - Supplementation with glycine and N-acetylcysteine (GlyNAC) appears to slow premature aging in people living with HIV (PWH), according to results from a
Polygenic risk score could spot people at higher risk for abdominal aortic aneurysm
By Will Boggs MD NEW YORK (Reuters Health) - Several genetic risk variants are associated with abdominal aortic aneurysm (AAA), and a polygenic risk score might help identify those who can benefit
Doctors in Delhi see jump in breathing issues amid COVID-19, pollution
By Neha Arora NEW DELHI (Reuters) - Top doctors in New Delhi are reporting a jump in respiratory problems among its residents, coinciding with the onset of peak pollution season in India's capital and
Risk of inflight spread of COVID-19 'very low', not zero - WHO
By Stephanie Nebehay GENEVA (Reuters) - The risk of COVID-19 spreading on flights appears "very low" but cannot be ruled out, despite studies showing only a small number of cases, the World Health
UPDATE 1-Polish court declares one of few remaining legal grounds for abortion unconstitutional
(Adds quotes, detail) By Marcin Goclowski and Anna Wlodarczak-Semczuk WARSAW (Reuters) - Poland's Constitutional Tribunal ruled on Thursday that abortion due to foetal defects was unconstitutional,
Polish court says abortion due to foetal defects is unconstitutional
By Reuters Staff WARSAW (Reuters) - Poland's Constitutional Tribunal ruled on Thursday that abortion on the grounds of foetal defects contravened the constitution, setting up a legal framework which
Sweden tells elderly to end isolation even as new virus cases rise
By Reuters Staff STOCKHOLM (Reuters) - Swedish senior citizens no longer need to isolate themselves, the government said on Thursday, pointing to lower COVID infection rates than in spring and a
Study finds AstraZeneca's COVID-19 vaccine follows genetic instructions
By Reuters Staff LONDON (Reuters) - AstraZeneca's Oxford COVID-19 vaccine accurately follows the genetic instructions programmed into it by its developers to successfully provoke a strong immune
EXCLUSIVE-In WHO overhaul push, EU urges changes to handling of pandemics
By Francesco Guarascio and Andreas Rinke BRUSSELS/BERLIN (Reuters) - The European Union wants the World Health Organization to become more transparent about how states report emerging health crises, a
European cities plead for more flu shots as winter looms, pandemic rages
By Alicja Ptak, Emilio Parodi and Francois Murphy WARSAW/MILAN/VIENNA (Reuters) - A surge in demand for vaccines to ward off the winter flu has led to shortages in some European cities, raising the
S.Korea sticks to flu vaccine plan despite safety fears after 25 die
By Hyonhee Shin and Sangmi Cha SEOUL (Reuters) - South Korean officials refused on Thursday to suspend a seasonal influenza inoculation effort, despite growing calls for a halt, including an appeal
REFILE-Per-oral endoscopic myotomy "reasonable" first-line treatment for idiopathic achalasia
(Corrects spelling of researcher's name, to Mundre, in paras 2 and 4 of Oct 19 story.) By Marilynn Larkin NEW YORK (Reuters Health) - Per-oral endoscopic myotomy (POEM) has comparable efficacy to
Local estrogen therapy for vaginal atrophy can start before or after age 60
By Marilynn Larkin NEW YORK (Reuters Health) - Treatment with low-dose local estrogen therapy (ET) to improve symptoms of vaginal atrophy may start before or after age 60, according to a post-hoc
DVT screening, early treatment, prevent PE in necrotizing pancreatitis
By Marilynn Larkin NEW YORK (Reuters Health) - Ultrasound screening enabled identification and early treatment of extremity deep vein thrombosis (DVT), thereby preventing symptomatic pulmonary
Women with cervical cancer at increased risk of injury during diagnostic workup
By Linda Carroll (Reuters Health) - Among the women who were screened for cervical cancer in Sweden, those with invasive cancer and carcinoma in situ were at increased risk of injury associated with
U.S. likely to have enough COVID-19 vaccines for all vulnerable Americans by year end -official
By Carl O'Donnell (Reuters) - The United States is likely to have enough safe and effective COVID-19 vaccines available to inoculate the most vulnerable Americans by the end of 2020, Health and Human
UPDATE 1-OxyContin maker Purdue reaches plea deal in opioid probe
(Adds details, background, that Sacklers propose ceding control of Purdue) By Mike Spector NEW YORK (Reuters) - Purdue Pharma LP agreed to plead guilty to criminal charges over the handling of its
Frailty, advanced age tied to less time at home after cancer resection
By Lisa Rapaport (Reuters Health) - Elderly, frail and low-income adults may have less time at home after cancer resection than patients who are younger and more affluent, a Canadian study suggests.
UPDATE 1-AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue
(Adds source comment on volunteer not being in active trial) By Eduardo Simões and Ricardo Brito SAO PAULO/BRASILIA (Reuters) - Brazilian health authority Anvisa said on Wednesday that a volunteer in
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue
By Eduardo Simões and Ricardo Brito SAO PAULO/BRASILIA (Reuters) - Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by
U.S. FDA panel to discuss COVID-19 vaccine trials after emergency authorization
By Reuters Staff (Reuters) - A panel of independent experts to the U.S. health regulator will decide on the nature of clinical trials that coronavirus vaccines should go through after receiving U.S.
UPDATE 1-Pompeo says U.S. still working to determine what caused 'Havana syndrome'
(Adds background, Pompeo quotes and details) By Reuters Staff WASHINGTON (Reuters) - The United States is still investigating what caused dozens of U.S. government employees in China and Cuba to
Epidural analgesia during labor might increase autism risk
By Will Boggs MD NEW YORK (Reuters Health) - Epidural analgesia during labor (LEA) is associated with an increased risk of autism-spectrum disorder in offspring, according to a retrospective study. "
Many people using CBD for diagnosable, treatable conditions
By Anne Harding NEW YORK (Reuters Health) - Many people are using cannabidiol (CBD) to treat diagnosable conditions for which evidence-based therapy is available, according to a new report. An
Mortality lower after coronary bypass surgery than after percutaneous interventions
By Will Boggs MD NEW YORK (Reuters Health) - All-cause and noncardiac mortality are lower among patients who undergo coronary-artery bypass grafting (CABG) than among those who undergo percutaneous
Pompeo says U.S. still working to determine what caused 'Havana syndrome'
By Reuters Staff WASHINGTON (Reuters) - The United States is still investigating what caused dozens of U.S. government employees in China and Cuba to become mysteriously ill, U.S. Secretary of State
Novel neuroimaging data have implications for recruitment for Alzheimer's clinical trials
By Reuters Staff NEW YORK (Reuters Health) - There is a quantitative association between initial beta-amyloid levels on positron emission tomography (PET) and subsequent tau accumulation on PET in
Bioenhanced curcumin may induce remission in ulcerative colitis
By Reuters Staff NEW YORK (Reuters Health) - A new curcumin formulation designed to improve oral bioavailability induces remission in patients with mild-to-moderate ulcerative colitis on maximal doses
Colorectal cancer more likely after first acute diverticulitis
By David Douglas NEW YORK (Reuters Health) - Acute diverticulitis, a leading cause of U.S. hospital admissions, is associated with an increased risk of subsequent colorectal cancer (CRC), according to
Intravascular lithotripsy safely treats severely calcified coronary-artery disease
By Will Boggs MD NEW YORK (Reuters Health) - Intravascular lithotripsy (IVL) is a safe and effective adjunct to stent implantation in severely calcified coronary-artery lesions, according to a
Guidelines promote deferred cord clamping for uncompromised preterm infants
By Lisa Rapaport (Reuters Health) - Deferred cord clamping for preterm infants is endorsed in 44 statements from 35 health organizations around the world, according to a review of clinical practice
OxyContin maker Purdue reaches plea deal in opioid probe
By Mike Spector NEW YORK (Reuters) - Purdue Pharma LP agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, in a deal with U.S. prosecutors that
Rates of bone density testing in men initiating ADT low but rising
By Lisa Rapaport (Reuters Health) - While bone mineral density (BMD) testing is becoming more common among men initiating androgen deprivation therapy (ADT) for prostate cancer, a Canadian study
France's AP-HP says Roche's Actemra limits need for ICU in COVID-19 patients
By Reuters Staff PARIS (Reuters) - A drug that fights inflammation made by Switzerland's Roche limits the need for a transfer to intensive care units for patients suffering from moderate to severe
Europe's hospitals under major stress as coronavirus cases surge
By Bart H. Meijer and Luis Felipe Castilleja AMSTERDAM/MADRID (Reuters) - Europe's hospital systems are at risk of buckling under the strain of soaring numbers of COVID-19 infections that have put the
Novartis to pursue SMA drug branaplam in Huntington's disease
By Reuters Staff ZURICH (Reuters) - Novartis is seeking to repurpose its investigational oral spinal muscular atrophy (SMA) drug branaplam to treat Huntington's disease, the Swiss drugmaker said on
United Airlines testing global health app on UK-U.S. flight in effort to reopen borders
By Tracy Rucinski CHICAGO (Reuters) - United Airlines is set on Wednesday to test a digital health pass under a global pilot program seeking to establish a common international standard for COVID-19
Cycling-Team doctor confirms Gaviria has been re-infected by COVID-19
By Reuters Staff (Reuters) - The cyclist Fernando Gaviria is one of only a handful of COVID-19 patients worldwide to have had the disease twice after his UAE Emirates team doctor confirmed on
ANALYSIS-Lack of antidotes adds to ethical dilemmas for UK COVID-19 challenge trials
By Kate Kelland LONDON (Reuters) - UK scientists seeking approval to deliberately infect healthy people with COVID-19 in trials must first convince ethics specialists that, among other things, they
Deaths after flu shots in S.Korea fan fears, but authorities find no link
By Sangmi Cha SEOUL (Reuters) - Nine people have died after getting flu shots in South Korea in the past week, raising concerns over the vaccine's safety just as the seasonal inoculation programme is
Lilly hires external adviser for COVID-19 drug plant problems
By Reuters Staff (Reuters) - Eli Lilly and Co said late on Tuesday it had hired an independent consultant to review a plant producing its COVID-19 antibody drug after receiving a notice from the U.S.
GSK to launch late-stage testing of RSV vaccine
By Reuters Staff FRANKFURT (Reuters) - GlaxoSmithKline said it would move its experimental vaccine against the respiratory syncytial virus (RSV), a cause of pneumonia in toddlers and the elderly, into
Survey probes U.S. adults' willingness to accept COVID-19 vaccine
By Will Boggs MD NEW YORK (Reuters Health) - A national survey that probed U.S. adults' likelihood of accepting a COVID-19 vaccine found efficacy was the most important attribute, with longer
U.S. reports about 300,000 more deaths than usual during pandemic - CDC
By Vishwadha Chander (Reuters) - Nearly 300,000 more people have died in the United States in 2020 during the coronavirus pandemic than expected based on historical trends, with about two-thirds of
CORRECTED-Mexico could absorb some COVID-19 vaccine liabilities
(Corrects headline and paragraph 1 to correct that government to accept some, not all liabilities) By Anthony Esposito and Adriana Barrera MEXICO CITY (Reuters) - Mexico's government could absorb some
Probiotics promising for Parkinson's constipation
By Marilynn Larkin NEW YORK (Reuters Health) - A multi-strain probiotics capsule effectively treated Parkinson's disease (PD)-related constipation in a short-term, single-center, randomized,
COVID-safe classroom strategy includes ventilation, glass screens on each desk
By Linda Carroll (Reuters Health) - A computer model of classroom airflow reveals "multilayer" strategies - including glass screens fastened to the front of desks, open windows, and air conditioning -
Mexico will pay for any COVID-19 vaccine liabilities, government says
By Anthony Esposito and Adriana Barrera MEXICO CITY (Reuters) - Mexico's government will pay to cover any liabilities arising from unexpected side effects of COVID-19 vaccines but is not considering
EXCLUSIVE-AstraZeneca U.S. COVID-19 vaccine trial may resume as soon as this week -sources
By Julie Steenhuysen and Marisa Taylor CHICAGO/WASHINGTON (Reuters) - AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and
Dermatitis herpetiformis may be common in patients with celiac disease
By Will Boggs MD NEW YORK (Reuters Health) - As many as 8% of patients with celiac disease (CD) may also have dermatitis herpetiformis (DH), and these patients are less likely to receive counseling on
COVID-19 more severe among some people with congenital heart disease
By Will Boggs MD NEW YORK (Reuters Health) - Patients whose congenital heart disease (CHD) stems from a genetic syndrome or is more physiologically advanced face an increased risk of moderate/severe
U.S. child mortality rates from road traffic accidents vary widely by county
By Lisa Rapaport (Reuters Health) - Across the U.S., disparities persist in child fatalities from road traffic accidents, with higher mortality rates in rural communities and counties without trauma
2,000 calories a day safe, more effective for refeeding anorexic patients
By Anne Harding NEW YORK (Reuters Health) - Higher-calorie refeeding (HCR) is safe and effective in closely monitored anorexia nervosa patients, a new randomized controlled trial shows. Patients who
Trifocal-lens implant frees most from spectacles after cataract surgery
By Anne Harding NEW YORK (Reuters Health) - Patients who receive trifocal-lens implants after cataract surgery are much less likely to need glasses than those who receive monofocal implants, according
Poverty contributes to higher infant mortality in rural areas
By Will Boggs MD NEW YORK (Reuters Health) - Socioeconomic disadvantages are a major contributor to the disparity in infant mortality between rural and nonrural parts of the U.S., and greater
Surgical valve explantation after TAVR tied to high short-term mortality
By David Douglas NEW YORK (Reuters Health) - Surgical valve explantation following successful transcatheter aortic-valve replacement (TAVR) because of factors including structural deterioration is
U.S. FDA meeting on COVID-19 vaccines to discuss criteria for emergency nod
By Reuters Staff (Reuters) - The U.S. health regulator's criteria for allowing emergency use of a COVID-19 vaccine and plans to monitor its safety after a regulatory go-ahead, are among the topics to
UPDATE 1-Most people would get COVID-19 vaccine if offered by government or employer - poll
(Adds link to study) By Josephine Mason LONDON (Reuters) - Most people would get a COVID-19 vaccine if their government or employer recommended it, results of a global poll showed on Tuesday, amid
Cold-chain-independent gel could deliver antibiotics for outer-ear infections with one application
By Scott Baltic NEW YORK (Reuters Health) - Researchers have developed a new single-application drug-delivery system for treating outer-ear infections that does not require refrigeration. A
California says it will independently review coronavirus vaccine
By Mimi Dwyer LOS ANGELES (Reuters) - A California panel of experts will independently review the safety of new coronavirus vaccines and initial plans for distribution, Governor Gavin Newsom said on
UK lab joins global network to compare coronavirus vaccine candidates
By Reuters Staff LONDON (Reuters) - A second British laboratory is joining a global lab network to assess data from potential coronavirus vaccines, set up by a major non-profit health emergencies
Most people would get COVID-19 vaccine if offered by government or employer - poll
By Josephine Mason LONDON (Reuters) - Most people would get a COVID-19 vaccine if their government or employer recommended it, results of a global poll showed on Tuesday, amid growing concerns about
UK plans COVID-19 'challenge' trials that deliberately infect volunteers
By Kate Kelland LONDON (Reuters) - Britain will help to fund trials using a manufactured COVID-19 virus to deliberately infect young healthy volunteers with the hope of accelerating the development of
REFILE-Study challenges idea that children are asymptomatic COVID-19 spreaders
(Corrects spelling of "Ospedale" in para 2, in story originally posted Sept 14.) By Megan Brooks NEW YORK (Reuters Health) - A study from Italy does not support the theory that children are more
REFILE-EXCLUSIVE-Study suggests dengue may provide some immunity against COVID-19
(Fixes coding on 9-21 story with no changes to text, to address formatting errors seen by some clients.) By Pedro Fonseca RIO DE JANEIRO (Reuters) - A new study that analyzed the coronavirus outbreak
